Nifedipine ๐
Related Subjects:
|Hypertension
|Acute Heart Failure
|Chronic Heart Failure
- ๐น Belongs to the dihydropyridine class of calcium channel blockers (CCBs).
- ๐ฉธ Acts as a peripheral vasodilator by relaxing vascular smooth muscle.
- ๐ Unlike verapamil/diltiazem, it has little effect on cardiac conduction โ not used for arrhythmias.
๐ฏ Indications
- โค๏ธ Hypertension (especially effective in older patients and Afro-Caribbean origin per NICE guidance).
- ๐ Angina pectoris (stable and vasospastic).
- โ๏ธ Raynaud phenomenon โ reduces vasospasm in fingers/toes.
- ๐งพ Unlicensed/off-label: oesophageal spasm, preterm labour (tocolysis).
๐ Interactions
- โฌ๏ธ Potentiates hypotension when combined with other BP-lowering drugs (e.g. beta-blockers, ACE inhibitors).
- ๐ Metabolised by CYP3A4 โ levels may rise with grapefruit juice, macrolides, or azole antifungals.
- โ Avoid short-acting nifedipine in acute coronary syndrome โ can cause reflex tachycardia and worsen ischaemia.
โ ๏ธ Side Effects
- ๐ง Headache, flushing, dizziness.
- ๐ฆต Ankle oedema (common, dose-related).
- ๐ฉ Constipation, malaise.
- โค๏ธ Rare but serious: bradycardia, AV block, worsening heart failure.
- ๐ฉธ Gingival hyperplasia with prolonged use.
๐ Dose
- ๐ Hypertension: Extended-release 30โ60 mg OD PO (max 120 mg/day).
Long-acting nifedipine 40โ80 mg OD.
- โค๏ธ Angina: 5โ20 mg PO TDS (short-acting; use with caution).
- โ๏ธ Raynaudโs: 5โ20 mg PO TDS.
- ๐งพ Oesophageal spasm (off-label): 10 mg PO TDS.
๐ References
๐ Teaching Points
- ๐ Preferred antihypertensive in Afro-Caribbean patients
- โ ๏ธ Avoid short-acting formulations in ischaemic heart disease due to risk of rebound tachycardia.
- ๐ง Peripheral oedema is not due to salt/water retention but to arteriolar dilation โ unresponsive to diuretics.
- ๐ Consider switching to another dihydropyridine (e.g. amlodipine) if ankle oedema intolerable.